// App-Quantinova.ai

2315 : Update On The Safety and Efficacy Of EXTENDed Treatment With Eltrombopag (EPAG) In Adults With Chronic Immune Thrombocytopenia (ITP)

Researchers

Presenter

  • James B Bussel

Principal Investigators

  • Mansoor N Saleh

  • Raymond S.M. Wong

  • Paul Burgess

  • Kalpana K. Bakshi

  • Geoffrey W. Chan

  • Christine K. Bailey

Medical Centers

  • Georgia Cancer Spclsts PC, Atlanta, GA

  • Department of Pediatrics, Division of Hematology, Weill Medical College of Cornell University, New York, NY

Locations

  • United States

Companies

  • GlaxoSmithKline plc.

Study Components

Therapeutic Area

  • Ophthalmology (OP)

Disease

  • Immune thrombocytopenia

  • Myocardial infarction

  • Deep vein thrombosis

  • Pulmonary embolism

  • Thrombocytopenia

  • Venous thrombosis

  • Cataract

Biomarkers

  • Alanine transaminase

  • Aspartate aminotransferase

  • Immunoglobulin G

Drug/Treatment

  • Oraprine

  • Eltrombopag

  • Danazol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved